|
Upcoming Events
10.19.08:
Health Advances to Lead Three Forums at National Licensing Executives Meeting
Three Health Advances' partners have been selected to lead program sessions at the 2008 annual meeting of the
Licensing Executive Society (LES), a professional association comprising over 6,000 members engaged in the transfer,
use, development, manufacture and marketing of intellectual property. The conference will be held in Orlando, Florida
from October 19 - 22.
Mark Speers, Partner, is organizing and leading a plenary session entitled "Biomarker Dealmaking."
He notes, "While there is a demonstrated need for easily accessible biomarkers, biomarker companies are experiencing
difficulties commercializing their innovations." Mark and executives from Pfizer, Monogram Biosciences, and Clarient
will examine the factors that encourage partnering of biomarker and drug companies and explore scenarios for profit
splits and royalty payments.
Skip Irving, Partner of Health Advances, will chair a workshop on "Building Franchises through Licensing
and M&A." Rarely can a company build or sustain a strong franchise soley with internally developed brands.
Franchise leaders and business development professionals for Biogen Idec and Takeda will discuss how matching
franchise objectives with the realities of asset availability and price/value considerations can lead to a clearer
vision of the priorities and high value opportunities.
Armed with her deep experience advising both early-stage biotech firms and large pharmaceutical companies,
Marie Schiller, Partner, is a natural choice to lead a panel of experts on "M&A Amongst Smaller
Companies." Marie points out that "we are involved with increasing M&A activity among small to mid-size
biopharmaceutical firms, fulfilling various needs, such as gaining worldwide access for regional companies,
increasing the number of products to offset R&D costs and risks, and/or to sustain funding in the event of
disappointing clinical trial results." Marie's panel will describe three case studies to demonstrate the
benefits associated with this M&A activity.
For more information, visit the LES website.
Orlando, FL
05.15.08:
Bill McPhee at Montréal InVivo
Bill McPhee, Director, will speak to Montréal InVivo on trends in the biotech financing process and deal making between
major pharmaceutical and biotech firms in Quebec and the US. The biotech industry in Quebec is seeking
alternatives to traditional venture financing. Health Advances has pioneered some new concepts in this area.
Montréal InVivo is the brand name for metro Montréal's Life Sciences cluster, a trade group of over 480 private companies and 150 public and university-based research organizations.
Montreal, QC
Recent Events
03.28.08:
Bill McPhee Featured at Mass Biotech Council's "Entrepreneurs' University"
Bill McPhee, Director, Health Advances, presented a session
on "Structuring Successful Strategic Alliances" for the Mass Biotech Council. Along with
John Hession, Managing Partner, Cooley Godward Kronish, Mr. McPhee discussed how
young medical device and biopharma companies can leverage alliances with large pharmaceutical
or medical device firms to increase their visibility and valuation and to attract new
investors as well as potential partners and acquirers. Mr. McPhee, a former venture
capital investor, develops creative, value-add partnering strategies for medical device
and biotech companies. Cambridge, MA
12.12.07:
Susan Posner on MIT Enterprise Forum Panel
MIT Enterprise Forum of Cambridge. Susan Posner, Vice President, Health Advances
participated in the Innovation Series Panel: Medical Devices - Executing on the Vision
The panel discussed achieving the corporate vision, including critical path planning
and execution necessary to achieve fair reimbursement for novel procedures and devices. Cambridge, MA
|
